Introduction
============

In early December 2019, a novel coronavirus disease (COVID-19), previously known as 2019-nCoV) induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China ([@ref-31]; [@ref-15]). This newly discovered coronavirus has been confirmed to have human-to-human transmissibility ([@ref-7]) and has now spread all over the country ([@ref-22]). However, it was reported that the mortality of COVID-19 was unbalanced in different regions ([@ref-22]). Briefly speaking, the mortality in Wuhan city was generally higher than that in other cities, and the mortality in Hubei Province was generally higher than that in non-Hubei regions (i.e., 33 other provinces in China except Hubei). Specific reasons need to be investigated so that we can better control the epidemic.

Despite receiving assistance nationwide, Wuhan, as the source of the epidemic in China, was under enormous treatment pressure. Many patients in Wuhan were unable to see a doctor and could not be hospitalized in time. The medical resources consumed by rescuing such patients further compressed the treatment options of other patients. Such a vicious circle caused by inappropriate resource allocation might be one of the reasons for the high mortality in Wuhan. In addition, by reviewing the outbreak of severe acute respiratory syndrome (SARS) in Guangdong in 2003, we could find that the SARS pandemic gradually subsided with the warming of the weather, and was basically controlled in the warm April and May. It was also reported that air temperature (AT) and other environmental factors, such as relative humidity (RH) and wind speed, might affect the SARS pandemic ([@ref-34]). Therefore, we assumed that differences in environmental factors in different regions might have contributed to the unbalanced mortality rate.

The first three makeshift hospitals (MSHs) Fangcang, Huoshenshan, and Leishenshan had been put into operation starting 5th of February 2020 ([@ref-10]). MSHs are mobile medical systems used in the field and are composed of several movable cabins. They have multiple functions, such as emergency treatment, surgical disposal, clinical examination, and so on. In case of any public health emergency, the cabins can build on the spot as soon as possible, and then in situ expand to a class II hospital ([@ref-1]). In the present study, we aimed to investigate whether these MSHs could reduce the mortality of COVID-19. Besides, we also investigated whether AT, RH, or air quality index (AQI, and the higher it is, the worser the air quality is) could affect the survival of COVID-19 patients.

Materials & Methods
===================

Data collection and mortality calculation
-----------------------------------------

From January 21 to February 21, 2020, daily total number of confirmed cases by nucleic acid testing, daily total number of severe cases (i.e., confirmed cases who met one of the following conditions: 1. Respiratory rate ≥ 30 times per minute; 2. Resting state oxygen saturation ≤ 93%; 3. Partial arterial pressure of oxygen (PaO2)/concentration of oxygen (FiO2) ≤ 300 mmHg) ([@ref-32]), and daily total number of deaths in Wuhan city, Hubei Province and non-Hubei regions (as a contrast so as to reduce bias) were collected by two authors independently. All the above data were available on the official website of Chinese National Health Commission (<http://www.nhc.gov.cn/>). Growth rate of confirmed cases was calculated using the following formula: $$\documentclass[12pt]{minimal}
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where

GR~n~ = the growth rate on day *n*

NC~n~ = the new cases on day *n*

TC~(*n*−1)~ = the total cases on day (*n* − 1)

And the daily mortality rate was calculated using the following formulas: $$\documentclass[12pt]{minimal}
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where

MCC~n~ = the mortality of confirmed cases on day *n*,

ND~n~ = the new deaths on day *n*,

TCC~n~ = the total confirmed cases on day *n*,

TCC~(*n*−1)~ = the total confirmed cases on day (*n* − 1),

MSC~n~ = the mortality of confirmed cases on day *n*,

TSC~n~ = the total severe cases on day *n*,

TSC~(*n*−1)~ = the total severe cases on day (*n* − 1).

The daily average data of three environmental factors, AT, RH, and AQI, were collected from Chinese Weather Net (<http://www.weather.com.cn/>), and the AT of Hubei Province was represented by the average AT of its seventeen cities (i.e., Wuhan, Huangshi, Shiyan, Yichang, Xiangyang, Ezhou, Jingmen, Xiaogan, Jingzhou, Huanggang, Xianning, Suizhou, Enshi, Xiantao, Qianjiang, Tianmen, and Shennongjia).

Statistical analysis
--------------------

First, outliers of the datasets were detected and then deleted using SPSS software. Second, the data was transformed using z-score normalization, a method to standardize observations obtained at different times and from different cohorts, thus allowing comparisons between these observations ([@ref-17]). It was assumed that T was the original time series and Z was the Z-normalized time series: $$\documentclass[12pt]{minimal}
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where  µ~*T*~ and  *σ*~*T*~ were the arithmetic mean value and standard variance of sequence T.

The data of each region was then divided into group A (from January 21 to February 5, before the use of MSHs) and group B (from February 6 to February 21, after the use of MSHs). Since the sample size was small (less than 50), the normality of the data was determined using Shapiro--Wilk test, and *P* value \> 0.05 was considered as normally distributed ([@ref-20]). If the data of the two groups were both normally distributed, Student's *t*-test would be performed to compare their difference, and if the data of at least one group had a skewed distribution, Mann--Whitney *U* test would be performed instead ([@ref-23]). We compared the data of four days, eight days, twelve days, and sixteen days after the use of MSHs, respectively, with the data of sixteen days before the use of MSHs. As for the correlation analysis, if the data of the environmental factors and the data of the growth rate/mortality were both normally distributed, Pearson correlation analysis would be performed to investigate the correlation between them, otherwise, Spearman's correlation analysis would be performed instead ([@ref-25]). SPSS 26.0 statistical software (IBM, New York, USA) was used for statistical data processing, and GraphPad Prism 8.3 (GraphPad Software Inc., New York, USA) was used to plot graphs. All tests were two-sided, and *P* value \< 0.05 was considered statistically significant.

Results
=======

Mortality difference before and after the use of MSHs
-----------------------------------------------------

Daily number of confirmed cases, severe cases, new deaths, and daily AT, RH, and AQI in different regions were summarized in [Table 1](#table-1){ref-type="table"}. The results of normality tests and the selection of statistical methods for comparative analyses are shown in [Table 2](#table-2){ref-type="table"}. As shown in [Fig. 1](#fig-1){ref-type="fig"} and [Table 3](#table-3){ref-type="table"}, no matter on day 4, day 8, day 12, or day 16 after the use of MSHs, the growth rates of confirmed cases were all significantly decreased both in Wuhan and Hubei; but in non-Hubei regions, changes were also significant.

As shown in [Fig. 2](#fig-2){ref-type="fig"} and [Table 3](#table-3){ref-type="table"}, eight days after the use of MSHs, the mortality of confirmed cases was significantly decreased both in Wuhan (*t* = 4.545, *P* \< 0.001) and Hubei (*U* = 0, *P* \< 0.001), (*t* and *U* are the test statistic used to test the significance of the difference), while in non-Hubei regions, in contrast, the mortality of confirmed cases remained unchanged (*U* = 76, *P* = 0.106). While on day 12 and day 16 after the use of MSHs, the reduce in mortality was still significant both in Wuhan and Hubei; but in non-Hubei regions, the reduce also became significant this time (*U* = 123, *P* = 0.036; *U* = 171, *P* = 0.015, respectively).
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###### Daily total number of confirmed cases, severe cases, new deaths and daily AT, RH, and AQI in different regions.

![](peerj-08-9578-g007)

           Wuhan                               Hubei           Non-Hubei regions                                                
  -------- ------- ----- ------ ------ ------- ------- ------- ------------------- ----- ------ ------ ------- -- ------- ----- ----
  20-Jan   258     6     --     --     --              270     51                  6     --     --     --         21      17    0
  21-Jan   363     3     6.0    90.0   104.0           375     65                  3     5.5    90.9   130.3      65      37    0
  22-Jan   425     8     4.0    91.0   106.0           444     71                  8     4.7    94.3   105.2      127     24    0
  23-Jan   495     6     5.0    96.0   49.0            549     129                 7     4.9    94.6   76.5       281     48    1
  24-Jan   572     15    5.5    94.0   61.0            729     157                 15    4.5    92.5   61.8       558     80    1
  25-Jan   618     7     3.0    89.0   81.0            1052    192                 13    3.3    87.9   74.2       923     132   2
  26-Jan   698     18    2.0    81.0   97.0            1423    290                 24    2.3    83.0   81.6       1321    171   0
  27-Jan   1590    22    2.5    92.0   90.0            2567    690                 24    2.4    86.7   74.2       1948    286   2
  28-Jan   1905    19    3.5    91.0   87.0            3349    899                 25    3.9    87.1   78.1       2625    340   1
  29-Jan   2261    25    5.5    94.0   96.0            4334    988                 37    5.6    86.0   87.8       3377    382   1
  30-Jan   2639    30    6.0    95.0   117.0           5486    1094                42    6.5    73.5   93.5       4206    433   1
  31-Jan   3215    33    6.5    93.0   102.0           6738    1294                45    7.2    70.9   109.8      5053    501   1
  1-Feb    4109    32    8.5    79.0   65.0            8565    1562                45    7.5    73.2   85.8       5815    548   0
  2-Feb    5142    41    8.5    85.0   121.0           9618    1701                56    7.4    85.4   112.3      7587    595   1
  3-Feb    6384    48    6.0    93.0   69.0            10990   2143                64    6.3    84.4   104.5      9448    645   0
  4-Feb    8351    49    7.0    94.0   183.0           12627   2520                65    7.7    85.3   119.8      11697   699   0
  5-Feb    10117   52    9.0    76.0   20.0            14314   3084                70    8.3    82.1   46.6       11988   775   3
  6-Feb    11618   64    5.0    92.0   47.0            15804   4002                69    3.8    92.7   48.5       13181   819   4
  7-Feb    13603   67    4.5    84.0   51.0            19835   5195                81    4.2    88.5   53.4       11939   906   5
  8-Feb    14982   63    5.5    96.0   66.0            20993   5247                81    6.4    87.5   62.7       12745   941   8
  9-Feb    16902   73    7.0    97.0   61.0            22160   5505                91    7.7    80.8   58.5       13822   979   6
  10-Feb   18454   67    7.5    89.0   55.0            25087   6344                103   8.2    90.4   59.5       12539   989   5
  11-Feb   19558   72    9.0    93.0   56.0            26121   7241                94    9.2    93.4   57.7       12679   963   3
  12-Feb   30043   82    11.0   97.0   50.0            43455   7084                107   10.7   93.4   53.5       9071    946   12
  13-Feb   32959   88    13.0   91.0   81.0            46806   9278                108   12.6   94.0   66.8       8942    926   5
  14-Feb   34289   77    11.0   92.0   36.0            48175   10152               105   10.2   81.2   27.8       8698    901   4
  15-Feb   35314   110   0.5    95.0   39.0            49030   10396               139   0.5    83.1   32.0       8386    876   3
  16-Feb   36385   76    2.0    95.0   30.0            49847   9797                100   3.8    78.6   34.1       8087    847   5
  17-Feb   37152   72    5.0    92.0   47.0            50338   10970               93    6.3    67.8   41.4       7678    771   5
  18-Feb   38020   116   7.5    59.0   59.0            50633   11246               132   7.3    57.7   67.1       7172    731   4
  19-Feb   37994   88    8.0    94.0   47.0            49665   11178               108   8.2    79.5   61.1       6638    686   6
  20-Feb   37448   99    10.0   75.0   80.0            48730   10997               115   9.9    67.5   65.5       6235    636   3
  21-Feb   36680   90    9.0    83.0   80.0            47647   10892               106   9.2    81.4   74.6       5637    585   3

**Notes.**

ATair temperatureRHrelative humidityAQIair quality index
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###### Tests of normality and selection of statistical methods for analyses of comparisons of 16 days before and 4, 8, 12, or 16 days after the use of MSHs.
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         Group      Shapiro--Wilk                                           
  ------ ---------- --------------- ---- --------- ------------------------ --
  GRW    Before     0.950           15   = 0.526                            
         After 4    0.996           4    = 0.986   Student's *t* test       
         After 8    0.969           7    = 0.894   Student's *t* test       
         After 12   0.928           11   = 0.392   Student's *t* test       
         After 16   0.944           15   = 0.434   Student's *t* test       
  MCW    Before     0.893           14   = 0.089                            
         After 4    0.886           3    = 0.342   Student's *t* test       
         After 8    0.982           7    = 0.968   Student's *t* test       
         After 12   0.960           11   = 0.776   Student's *t* test       
         After 16   0.932           15   = 0.289   Student's *t* test       
  GRH    Before     0.957           15   = 0.635                            
         After 4    0.792           4    = 0.089   Student's *t* test       
         After 8    0.811           7    = 0.053   Student's *t* test       
         After 12   0.805           11   = 0.011   Mann--Whitney *U* test   
         After 16   0.836           15   = 0.011   Mann--Whitney *U* test   
  MCH    Before     0.862           15   = 0.026                            
         After 4    0.895           4    = 0.408   Mann--Whitney *U* test   
         After 8    0.885           8    = 0.210   Mann--Whitney *U* test   
         After 12   0.899           12   = 0.156   Mann--Whitney *U* test   
         After 16   0.873           16   = 0.030   Mann--Whitney *U* test   
  MSH    Before     0.821           15   = 0.007                            
         After 4    0.990           4    = 0.955   Mann--Whitney *U* test   
         After 8    0.968           8    = 0.883   Mann--Whitney *U* test   
         After 12   0.964           12   = 0.845   Mann--Whitney *U* test   
         After 16   0.933           16   = 0.275   Mann--Whitney *U* test   
  GRNH   Before     0.860           15   = 0.024                            
         After 4    0.761           4    = 0.049   Mann--Whitney *U* test   
         After 8    0.890           7    = 0.273   Mann--Whitney *U* test   
         After 12   0.917           11   = 0.296   Mann--Whitney *U* test   
         After 16   0.881           15   = 0.049   Mann--Whitney *U* test   
  MCNH   Before     0.648           15   \<0.001                            
         After 4    0.938           4    = 0.640   Mann--Whitney *U* test   
         After 8    0.977           7    = 0.945   Mann--Whitney *U* test   
         After 12   0.944           11   = 0.570   Mann--Whitney *U* test   
         After 16   0.967           15   = 0.817   Mann--Whitney *U* test   
  MSNH   Before     0.704           15   \<0.001                            
         After 4    0.898           4    = 0.422   Mann--Whitney *U* test   
         After 8    0.926           7    = 0.521   Mann--Whitney *U* test   
         After 12   0.938           11   = 0.494   Mann--Whitney *U* test   
         After 16   0.918           15   = 0.181   Mann--Whitney *U* test   

**Notes.**

*P* \> 0.05 was considered as normally distributed.

Abbreviationsdfdegree of FreedomGRWgrowth rate of confirmed cases in WuhanBeforebefore the use of MSHsAfter 44 days after the use of MSHsAfter 88 days after the use of MSHsAfter 1212 days after the use of MSHsAfter 1616 days after the use of MSHsMCWmortality of confirmed cases in WuhanGRHgrowth rate of confirmed cases in HubeiMCHmortality of confirmed cases in HubeiMSHmortality of severe cases in HubeiGRNHgrowth rate of confirmed cases in non-Hubei regionsMCNHmortality of confirmed cases in non-Hubei regionsMSNHmortality of severe cases in non-Hubei regionMSHs"Fangcang, Huoshenshan, and Leishenshan" makeshift hospitals

As shown in [Fig. 3](#fig-3){ref-type="fig"} and [Table 3](#table-3){ref-type="table"}, four days after the use of MSHs, the mortality of severe cases was significantly decreased in Hubei (*U* = 0, *P* = 0.002); and in non-Hubei regions, in contrast, changes were not significant (*U* = 48, *P* = 0.080). Similarly, on day 8, day 12, and day 16 after the use of MSHs, the reduce in mortality was still significant both in Wuhan and Hubei; but in non-Hubei regions, the reduce also became significant (*U* = 82, *P* = 0.039; *U* = 129, *P* = 0.015; and *U* = 177, *P* = 0.007, respectively).

![Comparisons of the difference in the growth rate of confirmed cases between group A (16 days before the use of MSHs) and group B (4, 8, 12, or 16 days after the use of MSHs).\
When the data of the two groups were both normally distributed, Student's *t*-test was used to compare the difference; and when the data of at least one group had a skewed distribution, Mann--Whitney *U* test was used instead. The significance of the difference between 16 days before the use of MSHs and n days after the use of MSHs was represented by *P*~After n~, and *P*~After n~ \< 0.05 was considered statistically significant. Each box plot represents its corresponding dataset, and the bottom and top of the vertical line represent the minimum and maximum values of the dataset, respectively; the bottom and top of the box represent the first and third quartile of the dataset, respectively; and the horizontal line in the box represents the median value of the dataset. Before, 16 days before the use of MSHs; After 4, 4 days after the use of MSHs; After 8, 8 days after the use of MSHs; After 12, 12 days after the use of MSHs; After 16, 16 days after the use of MSHs; MSHs, makeshift hospitals. (A) Comparisons of the difference in the growth rate of confirmed cases in Wuhan. (B) Comparisons of the difference in the growth rate of confirmed cases in Hubei. (C) Comparisons of the difference in the growth rate of confirmed cases in non-Hubei regions.](peerj-08-9578-g001){#fig-1}

In brief, the mortality of confirmed and severe cases was found to be significantly decreased after the use of MSHs both in Wuhan and Hubei; while in non-Hubei regions, the reduction in mortality was not significant on day 4/day 8, but became significant over time.
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###### The difference in the growth rate/mortality of COVID-19 before and after the use of MSHs.
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                             Mann--Whitney *U* test                 
  ---------- --------------- ------------------------ ------------- ----------
  GRW        Before          0.211 (0.167, 0.255)                   
             After 4 days    0.137 (0.090, 0.184)     *t* = 1.801   = 0.089
             After 8 days    0.097 (0.079, 0.149)     *t* = 3.059   = 0.006
             After 12 days   0.084 (0.049, 0.118)     *t* = 4.656   \< 0.001
             After 16 days   0.060 (0.028, 0.093)     *t* = 5.889   \< 0.001
  GRH        Before          0.268 (0.158, 0.346)                   
             After 4 days    0.118 (−0.031, 0.268)    *t* = 2.520   = 0.022
             After 8 days    0.103 (0.035, 0.171)     *t* = 3.654   = 0.002
             After 12 days   0.072 (0.024, 0.121)     *U* = 8       \< 0.001
             After 16 days   0.050 (0.009, 0.090)     *U* = 8       \< 0.001
  GRNH       Before          0.450 (0.258, 0.642)                   
             After 4 days    0.039 (−0.104, 0.183)    *U* = 3       = 0.004
             After 8 days    0.008 (−0.066, 0.083)    *U* = 3       \< 0.001
             After 12 days   −0.008 (−0.053, 0.037)   *U* = 3       \< 0.001
             After 16 days   −0.026 (−0.061, 0.010)   *U* = 3       \< 0.001
  MCW (%)    Before          1.133 (0.892, 1.374)                   
             After 4 days    0.477 (0.357, 0.596)     *t* = 2.652   = 0.018
             After 8 days    0.340 (0.322, 0.478)     *t* = 4.545   \< 0.001
             After 12 days   0.341 (0.268, 0.413)     *t* = 6.812   \< 0.001
             After 16 days   0.319 (0.264, 0.375)     *t* = 7.102   \< 0.001
  MCH (%)    Before          1.013 (0.747, 1.279)                   
             After 4 days    0.433 (0.387, 0.479)     *U* = 0       = 0.001
             After 8 days    0.385 (0.320, 0.450)     *U* = 0       \< 0.001
             After 12 days   0.331 (0.266, 0.397)     *U* = 0       \<0.001
             After 16 days   0.307 (0.254, 0.360)     *U* = 0       \< 0.001
  MCNH (%)   Before          0.053 (0.005, 0.102)                   
             After 4 days    0.045 (0.023, 0.068)     *U* = 45      = 0.152
             After 8 days    0.043 (0.030, 0.056)     *U* = 76      = 0.106
             After 12 days   0.046 (0.037, 0.055)     *U* = 123     = 0.036
             After 16 days   0.049 (0.041, 0.058)     *U* = 171     = 0.015
  MSH (%)    Before          5.003 (3.586, 6.419)                   
             After 4 days    1.738 (1.476, 2.000)     *U* = 0       = 0.002
             After 8 days    1.337 (1.002, 1.657)     *U* = 0       \< 0.001
             After 12 days   1.434 (1.226, 1.642)     *U* = 0       \< 0.001
             After 16 days   1.335 (1.157, 1.514)     *U* = 0       \< 0.001
  MSNH (%)   Before          0.398 (0.071, 0.724)                   
             After 4 days    0.643 (0.393, 0.893)     *U* = 48      = 0.080
             After 8 days    0.560 (0.405, 0.716)     *U* = 82      = 0.039
             After 12 days   0.536 (0.434, 0.638)     *U* = 129     = 0.015
             After 16 days   0.548 (0.463, 0.634)     *U* = 177     = 0.007

**Notes.**

Test statistic was used to test the significance of the difference.

*P* \< 0.05 was considered as significantly different.

AbbreviationsLBlower boundUBupper boundGRWgrowth rate of confirmed cases in WuhanAfter 4 daysafter the use of MSHs for 4 daysAfter 8 daysafter the use of MSHs for 8 daysAfter 12 daysafter the use of MSHs for 12 daysAfter 16 daysafter the use of MSHs for 16 daysBeforebefore the use of MSHsMCWmortality of confirmed cases in WuhanGRHgrowth rate of confirmed cases in HubeiMCHmortality of confirmed cases in HubeiMSHmortality of severe cases in HubeiGRNHgrowth rate of confirmed cases in non-Hubei regionsMCNHmortality of confirmed cases in non-Hubei regionsMSNHmortality of severe cases in non-Hubei regionMSHs"Fangcang, Huoshenshan, and Leishenshan" makeshift hospitals

Correlation between environmental factors and outcomes
------------------------------------------------------

The results of normality tests and the selection of statistical methods for correlation analyses are shown in [Table 4](#table-4){ref-type="table"}. As shown in [Fig. 4](#fig-4){ref-type="fig"}. The negative correlation between the growth rate of confirmed cases and AT was not significant in Wuhan (*P* = 0.580), but significant in Hubei region (*r* =  − 0.644, *P* \< 0.001). There was a significant negative correlation between AT and the mortality of confirmed cases both in Wuhan (*r* =  − 0.460, *P* = 0.014) and Hubei (*r* =  − 0.535, *P* = 0.004). And the mortality of severe patients was also found to be negatively correlated with AT in Hubei (*r* =  − 0.522, *P* = 0.005). This means that, if the AT rises 1 Celsius, the mortality of confirmed cases would drop by about 0.5% and the mortality of severe cases would drop by 0.522% on average.

![Comparisons of the difference in the mortality of confirmed cases between group A (16 days before the use of MSHs) and group B (4, 8, 12, or 16 days after the use of MSHs).\
When the data of the two groups were both normally distributed, Student's *t*-test was used to compare the difference; and when the data of at least one group had a skewed distribution, Mann--Whitney *U* test was used instead. The significance of the difference between 16 days before the use of MSHs and n days after the use of MSHs was represented by *P*~After n~, and *P*~After n~ \< 0.05 was considered statistically significant. Each box plot represents its corresponding dataset, and the bottom and top of the vertical line represent the minimum and maximum values of the dataset, respectively; the bottom and top of the box represent the first and third quartile of the dataset, respectively; and the horizontal line in the box represents the median value of the dataset. Before, 16 days before the use of MSHs; After 4, 4 days after the use of MSHs; After 8, 8 days after the use of MSHs; After 12, 12 days after the use of MSHs; After 16, 16 days after the use of MSHs; MSHs, makeshift hospitals. (A) Comparisons of the difference in the mortality of confirmed cases in Wuhan. (B) Comparisons of the difference in the mortality of confirmed cases in Hubei. (C) Comparisons of the difference in the mortality of confirmed cases in non-Hubei regions.](peerj-08-9578-g002){#fig-2}

![Comparisons of the difference in the mortality of severe cases between group A (16 days before the use of MSHs) and group B (4, 8, 12, or 16 days after the use of MSHs).\
When the data of the two groups were both normally distributed, Student's t-test was used to compare the difference; and when the data of at least one group had a skewed distribution, Mann--Whitney *U* test was used instead. The significance of the difference between 16 days before the use of MSHs and n days after the use of MSHs was represented by *P*~After n~, and *P*~After n~ \< 0.05 was considered statistically significant. Each box plot represents its corresponding dataset, and the bottom and top of the vertical line represent the minimum and maximum values of the dataset, respectively; the bottom and top of the box represent the first and third quartile of the dataset, respectively; and the horizontal line in the box represents the median value of the dataset. Before, 16 days before the use of MSHs; After 4, 4 days after the use of MSHs; After 8, 8 days after the use of MSHs; After 12, 12 days after the use of MSHs; After 16, 16 days after the use of MSHs; MSHs, makeshift hospitals. (A) Comparisons of the difference in the mortality of severe cases in Hubei. (B) Comparisons of the difference in the mortality of severe cases in non-Hubei regions.](peerj-08-9578-g003){#fig-3}

As shown in [Fig. 5](#fig-5){ref-type="fig"}, no significant correlation between the growth rate of confirmed cases and RH was found no matter in Wuhan (*P* = 0.946) or Hubei (*P* = 0.144). The correlation between the mortality of confirmed cases and RH was also insignificant both in Wuhan (*P* = 0.943) and Hubei (*P* = 0.107). As for the mortality of severe cases, its correlation with RH in Hubei was also found to be insignificant (*P* = 0.128).
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###### Tests of normality and selection of statistical methods for correlation analyses.

![](peerj-08-9578-g010)

         Shapiro--Wilk                                                       
  ------ --------------- ---- --------- --------------------------------- -- --
  ATW    0.979           28   = 0.817                                        
  GRW    0.929           29   = 0.053   Pearson's correlation analysis       
  MCW    0.883           28   = 0.005   Spearman's correlation analysis      
  ATH    0.973           27   = 0.676                                        
  GRH    0.944           28   = 0.137   Pearson's correlation analysis       
  MCH    0.882           27   = 0.005   Spearman's correlation analysis      
  MSH    0.863           27   = 0.002   Spearman's correlation analysis      
  RHW    0.838           29   \<0.001                                        
  GRW    0.927           30   = 0.042   Spearman's correlation analysis      
  MCW    0.874           29   = 0.003   Spearman's correlation analysis      
  RHH    0.937           28   = 0.094                                        
  GRH    0.944           29   = 0.125   Pearson's correlation analysis       
  MCH    0.874           28   = 0.003   Spearman's correlation analysis      
  MSH    0.854           28   = 0.001   Spearman's correlation analysis      
  AQIW   0.920           30   = 0.026                                        
  GRW    0.906           30   = 0.012   Spearman's correlation analysis      
  MCW    0.866           30   = 0.001   Spearman's correlation analysis      
  AQIH   0.969           28   = 0.551                                        
  GRH    0.936           29   = 0.080   Pearson's correlation analysis       
  MCH    0.848           28   = 0.001   Spearman's correlation analysis      
  MSH    0.824           28   \<0.001   Spearman's correlation analysis      

**Notes.**

*P* \> 0.05 was considered as normally distributed.

Abbreviationsdfdegree of FreedomATWair temperature in WuhanGRWgrowth rate of confirmed cases in WuhanMCWmortality of confirmed cases in WuhanATHair temperature in HubeiGRHgrowth rate of confirmed cases in HubeiMCHmortality of confirmed cases in HubeiMSHmortality of severe cases in WuhanRHWrelative humidity in WuhanRHHrelative humidity in HubeiAQIWair quality index in WuhanAQIHair quality index in Hubei

As shown in [Fig. 6](#fig-6){ref-type="fig"}, the growth rate of confirmed cases was found to be significantly correlated with AQI both in Wuhan (*r* = 0.373, *P* = 0.042) and Hubei (*r* = 0.426, *P* = 0.021). And the correlation between the mortality of confirmed cases and AQI was also significant in Wuhan (*r* = 0.620, *P* \< 0.001) and Hubei (*r* = 0.634, *P* \< 0.001). As for the mortality of severe cases, its correlation with AQI in Hubei was also significant (*r* = 0.622, *P* \< 0.001). This means that, if the AQI drops 1 unit, the mortality of confirmed cases might drop by about 0.63% and the mortality of severe cases might drop by about 0.622%.

In brief, the mortality of confirmed/severe cases was negatively correlated with AT no matter in Wuhan or in Hubei, while the negative correlation between the growth rate of confirmed cases and AT was significant in Hubei, but not significant in Wuhan. In addition, both the growth rate and the mortality of COVID-19 cases were significantly correlated with AQI, but not with RH.

![Correlation between air temperature and growth rate/mortality of COVID-19 cases.\
When the data of the air temperature and the corresponding outcome were both normally distributed, Pearson's analysis was performed to investigate their correlation; otherwise, Spearman's analysis was performed instead. The correlation coefficient *r* measures the strength and direction of the linear relationship between the two variables. Positive *r* or negative *r* represents positive correlation or negative correlation, respectively, and the closer *r* is to +1 or −1, the more closely the two variables are related. *P*-value was used to test the significance of the correlation, and *P* \< 0.05 was considered statistically significant. (A) Correlation between air temperature and the growth rate of confirmed cases in Wuhan. (B) Correlation between air temperature and the growth rate of confirmed cases in Hubei. (C) Correlation between air temperature and the mortality of confirmed cases in Wuhan. (D) Correlation between air temperature and the mortality of confirmed cases in Hubei. (E) Correlation between air temperature and the mortality of severe cases in Hubei.](peerj-08-9578-g004){#fig-4}

Discussion
==========

Our study found that after the use of MSHs, the mortality of COVID-19 patients in Wuhan and Hubei was significantly decreased compared with non-Hubei regions at the beginning. The results preliminarily verified that these MSHs were beneficial to the survival of COVID-19 patients. After the MSHs operated effectively, they could focus on the isolation and treatment of patients with mild symptoms, thereby reducing the pressure placed on traditional hospitals, so that the later could devote more energy to rescuing patients with severe symptoms. In this way, medical resources could be better utilized and patients could be better treated, and this might be the mechanism through which MSHs worked. Later, with the passing of time, the difference in mortality before and after the use of MSHs was still significant both in Wuhan and Hubei. However, the difference became also significant in the non-Hubei regions, which means that some other factors might also contribute to reducing the mortality. We thought that the accumulation of medical staff's treatment experience might be one of the potential reasons. In addition, according to the trade-off hypothesis, a pathogen must multiply within the host to ensure transmission, while simultaneously maintaining opportunities for transmission by avoiding host morbidity or death ([@ref-4]); this means that SARS-CoV-2 with weak virulence was more likely to spread than that with strong virulence, which might explain why the mortality in non-Hubei regions also decreased over time. However, empirical evidence remains scarce and the truth needs to be further investigated.

![Correlation between relative humidity and growth rate/mortality of COVID-19 cases.\
When the data of the air temperature and the corresponding outcome were both normally distributed, Pearson's analysis was performed to investigate their correlation; otherwise, Spearman's analysis was performed instead. The correlation coefficient *r* measures the strength and direction of the linear relationship between the two variables. Positive *r* or negative *r* represents positive correlation or negative correlation, respectively, and the closer *r* is to +1 or −1, the more closely the two variables are related. *P*-value was used to test the significance of the correlation, and *P* \< 0.05 was considered statistically significant. (A) Correlation between relative humidity and the growth rate of confirmed cases in Wuhan. (B) Correlation between relative humidity and the growth rate of confirmed cases in Hubei. (C) Correlation between relative humidity and the mortality of confirmed cases in Wuhan. (D) Correlation between relative humidity and the mortality of confirmed cases in Hubei. (E) Correlation between relative humidity and the mortality of severe cases in Hubei.](peerj-08-9578-g005){#fig-5}

![Correlation between air quality index and growth rate/mortality of COVID-19 cases.\
When the data of the air temperature and the corresponding outcome were both normally distributed, Pearson's analysis was performed to investigate their correlation; otherwise, Spearman's analysis was performed instead. The correlation coefficient *r* measures the strength and direction of the linear relationship between the two variables. Positive *r* or negative *r* represents positive correlation or negative correlation, respectively, and the closer *r* is to +1 or -1, the more closely the two variables are related. *P*-value was used to test the significance of the correlation, and *P*0.05 was considered statistically significant. (A) Correlation between air quality index and the growth rate of confirmed cases in Wuhan. (B) Correlation between air quality index and the growth rate of confirmed cases in Hubei. (C) Correlation between air quality index and the mortality of confirmed cases in Wuhan. (D) Correlation between air quality index and the mortality of confirmed cases in Hubei. (E) Correlation between air quality index and the mortality of severe cases in Hubei.](peerj-08-9578-g006){#fig-6}

Our study also found that the rise of AT could significantly reduce the mortality of both confirmed and severe cases. According to a previous study, the deaths that occurred were mainly elderly people who had comorbidities or surgery history before admission ([@ref-9]). Acute or chronic cold exposure was reported to have adverse effects on the respiratory system, such as increasing pulmonary vascular resistance, increasing numbers of goblet cells and mucous glands, and increasing muscle layers of terminal arteries and arterioles, which might be associated with the symptoms of chronic obstructive pulmonary disease, high altitude pulmonary hypertension, and right heart hypertrophy ([@ref-14]). It was also reported that cold exposure was usually accompanied by hormonal changes, which might directly or indirectly alter the immune system ([@ref-30]). The above factors would worsen the underlying medical conditions of elderly people, and this might explain why warm weather could reduce the mortality of COVID-19 patients. When it comes to the transmissibility of coronavirus, a previous *in vitro* study found that when the AT was lower, gastroenteritis virus and mouse hepatitis virus could survive longer on stainless steel surface than when the AT was higher ([@ref-6]). A case-crossover analysis performed in Saudi Arabia also found that primary Middle East Respiratory Syndrome were more likely to occur when the climate was relatively cold and dry ([@ref-13]). Some earlier studies on SARS also pointed out that the SARS cases were negatively correlated with AT ([@ref-3]), and it was estimated that in days with a lower AT during the epidemic, the risk of increased daily incidence of SARS was 18.18-fold (95% confidence interval 5.6--58.8) higher than in days with a higher AT ([@ref-19]); and as the AT rose, SARS cases tended to decrease afterwards ([@ref-33]). In our study, although the growth rate of confirmed cases was found to be negatively correlated with AT in Hubei Province, the correlation was not significant in Wuhan City. The specific reason for this inconsistency needs to be further investigated, and one of the potential reasons might be that the basic number of COVID-19 cases in Wuhan was so large that the change of AT was not enough to affect the disease transmission. In addition, it was proposed by [@ref-29] that the optimal AT for SARS occurrence was 16 °C to 28 °C and 18 °C to 22 °C ([@ref-18]); while in our study, the daily AT were all less than 13C,˚ therefore, another potential reason might be that the current AT was not high enough to exert a significant impact on SARS-CoV-2. As the AT rises, subsequent studies including more regions and a wider range of AT are necessary to further validate our results.

As for RH, it was reported that compared with other human coronaviruses, SARS coronaviruses and MERS coronaviruses appeared to have an unusual capacity to survive on dry surfaces ([@ref-8]; [@ref-24]; [@ref-21]; [@ref-28]; [@ref-12]). SARS coronaviruses could survive for more than 6 days when dried on a Petri dish, while human coronavirus HCoV-229E could only survive for less than 3 days ([@ref-24]). It was also reported that SARS coronavirus viability was lost more rapidly at higher RH (e.g., RH of \> 95%) than at lower RH (e.g., RH of 40--50%) ([@ref-8]). However, in our study, no significant correlation between RH and the growth rate/mortality of COVID-19 cases was found. The relatively small sample size and the small range of daily RH in our study (most are of 75--95%) might be one of the potential reasons for our negative results. Besides, as a new type of coronaviruses, SARS-CoV-2 might have obtained the ability to withstand higher RH. In any case, more studies are still needed to further investigate the correlation between RH and the growth rate/mortality of COVID-19 cases.

Another discovery of our study was that both the growth rate and mortality of COVID-19 were significantly correlated with AQI. This means that the worse the air quality is, the higher the growth rate/mortality of COVID-19 might be. This finding was consistent with a previous study, in which patients in regions with moderate air pollution levels were found to be more likely to die than those in regions with low air pollution levels. Prolonged exposure to air pollution has been linked to acute respiratory inflammation, asthma attack, and death from cardiorespiratory diseases in various studies ([@ref-2]; [@ref-26]; [@ref-11]; [@ref-27]). Several potential mechanistic pathways have also been described, which include oxidative injury to the airways, leading to inflammation, enhanced coagulation/thrombosis, a propensity for arrhythmias, acute arterial vasoconstriction, systemic inflammation responses, and the chronic promotion of atherosclerosis ([@ref-16]; [@ref-5]). These factors could increase the vulnerability of a population to COVID-19 and aggravate the respiratory and pre-existing cardiovascular symptoms of COVID-19 patients, which might explain the significant correlation between the growth rate/mortality of COVID-19 cases and AQI.

In this study, we tried to evaluate the effects of MSHs and explore the relation between environmental factors and the growth rate/mortality of COVID-19. We believe that our findings will give some guidance to the current anti-epidemic work and future research. Nevertheless, there are some limitations in our study that should be discussed. First, we could not exclude effects of many other factors, such as ultraviolet intensity, wind speed, air pressure and so on, on the disease transmission or severity, but we could not specifically address these parameters due to lack of data. Second, since most patients were isolated at home or in MSHs, where the temperature was slightly different from the AT outside, some deviation might have been caused. Third, the sample size of 32 days was not so big for the comparisons and correlation analyses, which might have also caused some selection bias.

Conclusions
===========

In conclusion, the use of MSHs, the rise of AT, and the improvement of air quality were all found to be associated with a better survival of COVID-19 patients, while RH seemed to have no effect on the growth rate/mortality of COVID-19 patients. Since the sample size in our study was rather small, studies including more regions and larger sample size are urgently needed to further validate our findings.
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